Mylan has faced investor pushback on its executive pay and governance for years and its 2019 shareholder's meeting was no exception.
Investors called on Mylan to expand its executive pay clawbacks—and now, the question is whether the company will actually take that advice.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,